Did Gerald waste a year? With the economy and world on the edge, did Gerald fool around for too long with Lympro? Will releasing it in the wake of another possible economic downturn hurt Amarantus yet again?
How will the market respond? Will Amarantus be able to net significant revenues? Jason Napadano seems to think (without explaining why he thinks so) Lympro won't generate a lot of revenue in fiscal 2015. Gerald's job is on the line.

And how can I forget that Sierra is predicting that AMBS is going to be bought out so that means many of us can then pay off our high interest loans.